Johnson & Johnson plans $55 billion U.S. investment, cites Trump-era tax policies

Johnson & Johnson said it will invest $55 billion in the United States over the coming years to expand manufacturing for medicines, medical technology and vision products, including more than $1 billion for a new facility in Jacksonville, Florida. CEO Joaquin Duato said the decision was supported by Trump-era tax policies, access to domestic talent and what he called an improved investment environment. He also said the company is focusing on science and innovation and sees a path to double-digit growth by the end of the decade, supported by 28 product platforms generating more than $1 billion each.